- Institut de Recerca Biomèdica de Lleida (IRB-Lleida)
Institut d'investigació
![Foto de - Institut de Recerca Biomèdica de Lleida (IRB-Lleida)](/img/noimage.png)
![Foto de Institute Catalá Oncología](/img/noimage_org.png)
Institute Catalá Oncología
Barcelona, EspañaPublications en collaboration avec des chercheurs de Institute Catalá Oncología (47)
2024
-
“For and against” factors influencing participation in personalized breast cancer screening programs: a qualitative systematic review until March 2022
Archives of Public Health, Vol. 82, Núm. 1
2023
-
Adaptation, implementation, and evaluation of an online health sciences training program for brief smoking intervention: A pre-post study in four European countries
Nurse education today, Vol. 130, pp. 105924
-
Development of a Guide to Multidimensional Needs Assessment in the Palliative Care Initial Encounter (MAP)
Journal of Pain and Symptom Management, Vol. 66, Núm. 4, pp. 361-369.e6
-
Exposure to secondhand and thirdhand smoke in private vehicles: Measurements in air and dust samples
Environmental Research, Vol. 235
-
Measurement of airborne nicotine, as a marker of secondhand smoke exposure, in homes with residents who smoke in 9 European countries
Environmental Research, Vol. 219
2022
-
Women's preference to apply shared decision-making in breast cancer screening: a discrete choice experiment
BMJ Open, Vol. 12, Núm. 11
2021
-
Burden of disease from exposure to secondhand smoke in children in Europe
Pediatric Research, Vol. 90, Núm. 1, pp. 216-222
-
Switching Ratio from Parenteral to Oral Methadone 1:1.2 Is Safer Compared with Ratio 1:2 in Patients with Controlled Cancer Pain: A Multicenter Randomized-Controlled Trial (RATIOMTD-010810)
Journal of Palliative Medicine, Vol. 24, Núm. 3, pp. 382-390
2020
-
Proactive and systematic multidimensional needs assessment in patients with advanced cancer approaching palliative care: A study protocol
BMJ Open, Vol. 10, Núm. 2
-
T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma
Journal of Investigative Dermatology, Vol. 140, Núm. 6, pp. 1253-1265
2019
-
Burden of disease attributable to second-hand smoke exposure: A systematic review
Preventive Medicine, Vol. 129
-
Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease
Cell, Vol. 177, Núm. 4, pp. 881-895.e17
-
Effect of information about the benefits and harms of mammography on women’s decision making: The InforMa randomised controlled trial
PLoS ONE, Vol. 14, Núm. 3
-
Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: The ULTRA trial
Annals of Oncology, Vol. 30, Núm. 5, pp. 796-803
-
Tumor expression of cyclin-dependent kinase 5 (Cdk5) is a prognostic biomarker and predicts outcome of oxaliplatin-treated metastatic colorectal cancer patients
Cancers, Vol. 11, Núm. 10
2018
-
Characteristics of the case mix, organisation and delivery in cancer palliative care: A challenge for good-quality research
BMJ Supportive and Palliative Care, Vol. 8, Núm. 4, pp. 456-467
2017
-
Assessment of the effects of decision aids about breast cancer screening: A systematic review and meta-analysis
BMJ Open, Vol. 7, Núm. 10
-
Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer
Autophagy, Vol. 13, Núm. 3, pp. 608-624
-
Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer (Nature Genetics (2014) 46 (736-741))
Nature Genetics
-
Cost-effectiveness of strategies to increase screening coverage for cervical cancer in Spain: the CRIVERVA study
BMC Public Health, Vol. 17, Núm. 1